Skip to content

Clinical trials

Observational Lung Diseases, Interstitial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Observational Country / region: United States Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20061
20072
20082
20091
20101
20111
20121
20134
20141
20152
20163
20173
20185
20202
20218
20224
20237
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting13
Unknown status6
Terminated4
Enrolling by invitation3
Active, not recruiting2
Suspended1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Columbia University4
National Jewish Health4
Boehringer Ingelheim3
Pulmonary Care and Research Collaborative Limited3
Lahey Clinic2
Lung Institute2
National Heart, Lung, and Blood Institute (NHLBI)2
Northwell Health2
Ohio State University2
Pulmonary Fibrosis Foundation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial60
Idiopathic Pulmonary Fibrosis19
Pulmonary Fibrosis16
Pulmonary Disease, Chronic Obstructive9
Lung Diseases8
Alveolitis, Extrinsic Allergic6
Arthritis, Rheumatoid6
Hypertension, Pulmonary6
Sarcoidosis6
Connective Tissue Diseases5

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.